Recent Articles from Chartmill
ChartMill is a comprehensive online stock research platform designed to empower traders and investors with advanced tools for technical and fundamental analysis. The company provides a robust stock screener that allows users to filter thousands of stocks across major exchanges like NYSE, NASDAQ, and EURONEXT, using over 180 customizable technical and fundamental parameters to identify trading opportunities.
Website: https://www.chartmill.com
Cargurus (NASDAQ:CARG) is an undervalued stock with strong fundamentals—low P/E, zero debt, high profitability, and solid growth potential, making it a promising pick for value investors.
Via Chartmill · August 5, 2025
FOX Corp (NASDAQ:FOX) is a strong value investing pick with low P/E, high profitability, solid financials, and steady growth, trading below its true worth.
Via Chartmill · August 5, 2025
DexCom (DXCM) offers strong growth, fair valuation, and solid profitability, making it a top pick for investors seeking affordable growth in the medical device sector.
Via Chartmill · August 5, 2025
Zimmer Biomet (ZBH) offers steady dividends with 10+ years of payouts, strong profitability, and financial health, making it a reliable pick for long-term dividend investors.
Via Chartmill · August 5, 2025
Essent Group Ltd (ESNT) is a value stock with strong fundamentals—low P/E, solid financial health, and steady earnings—making it an attractive pick for value investors seeking undervalued opportunities.
Via Chartmill · August 5, 2025
Planet Fitness (PLNT) shows strong technical breakout potential with top ratings for momentum and setup quality, backed by solid support and institutional interest.
Via Chartmill · August 5, 2025
Johnson & Johnson (JNJ) is a top dividend stock with a 3.16% yield, consistent growth, and strong profitability, making it ideal for income investors seeking stability.
Via Chartmill · August 5, 2025
Louis Navellier’s growth investing strategy highlights stocks like RIGL with strong earnings momentum, rising sales, and profitability, making it a standout pick for investors.
Via Chartmill · August 5, 2025
NVO offers dividend investors a strong 3.62% yield, 16.56% growth, and high profitability, backed by solid financial health and growth potential.
Via Chartmill · August 5, 2025
Kiniksa Pharmaceuticals (KNSA) aligns with Minervini’s Trend Model, showing strong technicals, rapid earnings growth, and upward momentum—ideal for growth investors.
Via Chartmill · August 5, 2025
A strong tech-led rally drove U.S. stocks higher Monday, shaking off last week's weak jobs data. But Warren Buffett’s Berkshire Hathaway took a hit after underwhelming earnings and sluggish insurance growth.
Via Chartmill · August 5, 2025
Vornado Realty Trust (VNO) reported Q2 2025 earnings with EPS beating estimates by 540% at $0.56, while revenue missed at $441.44M. Stock rose 0.62% after-hours.
Via Chartmill · August 4, 2025
Armada Hoffler Properties reports mixed Q2 2025 results, with FFO beating estimates but GAAP net income at $0.04. Revenue slightly exceeded expectations at $65.15M. Stock remains flat post-release.
Via Chartmill · August 4, 2025
Kyndryl Q1 2026 earnings: $3.74B revenue missed estimates, but $0.37 EPS beat. Stock fell 7.7% amid revenue concerns. Future outlook remains uncertain.
Via Chartmill · August 4, 2025
EverQuote (EVER) reported Q2 2025 results with revenue of $156.6M (+34% YoY) missing estimates, while EPS of $0.39 beat. Shares fell 8.4% post-earnings.
Via Chartmill · August 4, 2025
Tactile Medical (TCMD) beats Q2 2025 estimates with $78.91M revenue and $0.14 EPS, driving an 8.7% after-hours stock surge. Strong demand for chronic care devices fuels growth.
Via Chartmill · August 4, 2025
MSA Safety Inc (NYSE:MSA) reported Q2 2025 earnings, beating revenue and EPS estimates with $474.1M and $1.93, respectively. Despite the beat, shares saw muted market reaction.
Via Chartmill · August 4, 2025
Navitas Semiconductor (NVTS) reports Q2 2025 earnings with revenue missing estimates at $14.5M but EPS slightly beating at -$0.05. Shares dropped 13.3% post-announcement. Focus remains on AI and energy growth.
Via Chartmill · August 4, 2025
The Andersons Inc. reported mixed Q2 2025 results, with revenue beating estimates but EPS missing. The $425M TAMH acquisition aims to strengthen its biofuels segment. Investors remain cautious amid profitability challenges.
Via Chartmill · August 4, 2025
Palomar Holdings (PLMR) reported Q2 2025 earnings with EPS beating estimates at $1.76, but revenue missed by 58.4%. Shares fell 4% amid growth concerns.
Via Chartmill · August 4, 2025
Ryman Hospitality Properties (NYSE:RHP) exceeded Q2 earnings and revenue estimates, yet shares remained flat amid broader sector caution. Strong group demand and cost efficiency drove growth.
Via Chartmill · August 4, 2025
Transocean Ltd. (NYSE:RIG) posted mixed Q2 2025 results with revenue beating estimates but EPS missing slightly. Stock rose 1.78% after-hours as investors weigh profitability challenges.
Via Chartmill · August 4, 2025
Danaos Corp (NYSE:DAC) reported mixed Q2 2025 results, missing revenue and EPS estimates. Shares dipped slightly as investors reacted to weaker-than-expected performance.
Via Chartmill · August 4, 2025
Viper Energy (VNOM) beats Q2 2025 earnings & revenue estimates with $297M sales and $0.41 EPS, driven by strong Permian Basin royalty interests. Stock remains flat post-release.
Via Chartmill · August 4, 2025
Unitil Corp's Q2 2025 results show mixed performance with revenue slightly beating estimates but EPS slightly missing. Adjusted earnings rose, while GAAP net income declined. Market reaction remained muted.
Via Chartmill · August 4, 2025
Mueller Water Products (MWA) Q3 2025 earnings beat estimates with $380.3M revenue and $0.34 EPS, but shares remain flat amid muted market reaction.
Via Chartmill · August 4, 2025
Centerspace (CSR) Q2 2025 earnings beat EPS estimates at $1.28 vs. -$0.12, revenue in line at $68.55M. Stock remains flat despite strong results.
Via Chartmill · August 4, 2025
UFP Technologies reports record Q2 2025 earnings, beating EPS estimates but slightly missing revenue. Shares dip 1% amid mixed market reaction. Strong YoY growth in medical device demand.
Via Chartmill · August 4, 2025
Commercial Vehicle Group Inc (CVGI) posted mixed Q2 2025 results, beating revenue estimates but reporting a wider loss. Shares rose 3.24% after-hours, reflecting investor optimism on strong cash flow and sales growth.
Via Chartmill · August 4, 2025
Encompass Health (EHC) beat Q2 2025 earnings estimates with $1.46B revenue and $1.40 EPS, raising full-year guidance. Stock surged 3.38% post-announcement.
Via Chartmill · August 4, 2025
SI-BONE INC reports mixed Q2 2025 results with revenue slightly below estimates but beats on EPS, driving a positive market reaction. Strong growth and raised guidance signal confidence.
Via Chartmill · August 4, 2025
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · August 4, 2025
ZoomInfo Q2 2025 earnings beat estimates with $306.7M revenue and $0.25 EPS, sparking a 6.95% stock surge. New CFO appointment and strong demand for its intelligence platform drive optimism.
Via Chartmill · August 4, 2025
ODDITY Tech (NASDAQ: ODD) beat Q2 2025 revenue and EPS estimates but saw a 13% stock drop post-earnings. Strong profitability contrasts with investor concerns over future growth. Full-year outlook raised, yet market reaction remains cautious.
Via Chartmill · August 4, 2025
Ardelyx (ARDX) Q2 2025 earnings beat estimates with $97.7M revenue (+33% YoY) and -$0.08 EPS. Strong IBSRELA & XPHOZAH sales drove growth, sparking an 11.6% after-hours stock surge.
Via Chartmill · August 4, 2025
Semler Scientific (SMLR) reported a strong Q2 2025 earnings beat with $5.04 EPS, while revenue slightly missed estimates. The firm holds 5,021 BTC, yielding 31.3%, driving investor interest. Stock rose 1.07% post-release.
Via Chartmill · August 4, 2025
Allegiant Travel Co (ALGT) reports mixed Q2 2025 results, beating EPS estimates by 59.3% but missing revenue forecasts. Stock declines amid muted market reaction.
Via Chartmill · August 4, 2025
Diamondback Energy (FANG) reported mixed Q2 2025 results, beating revenue estimates at $3.678B but missing EPS at $2.67. Shares dipped 1.7% post-earnings.
Via Chartmill · August 4, 2025
Denny's Q2 2025 results missed revenue and EPS estimates, with shares declining amid broader underperformance. Expansion continues for Keke's, but investor confidence wanes.
Via Chartmill · August 4, 2025
Syndax Pharmaceuticals reported mixed Q2 2025 results, beating revenue estimates with $37.96M but posting an EPS loss of ($0.83). Revuforj sales surged 43%, while shares dipped 3.66% post-earnings.
Via Chartmill · August 4, 2025
CVRx reported Q2 2025 revenue of $13.59M, beating estimates, but EPS missed at -$0.57. Shares dipped slightly as losses widened despite steady Barostim commercialization.
Via Chartmill · August 4, 2025
Vertex Q2 2025 earnings beat estimates, but stock dropped 13% after discontinuing acute pain drug VX-993. Focus remains on CF and other key programs.
Via Chartmill · August 4, 2025
Dorman Products (DORM) beats Q2 2025 estimates with $541M revenue & $2.06 EPS, raises full-year guidance. Shares surge 6.69% post-earnings.
Via Chartmill · August 4, 2025
Simon Property Group (SPG) beat Q2 2025 earnings estimates, raised guidance, and increased its dividend, signaling strong financial health and investor confidence.
Via Chartmill · August 4, 2025
Castle Biosciences (CSTL) Q2 2025 earnings beat estimates with $86.19M revenue & $0.15 EPS, driving a 6% after-hours surge. Strong test volume growth fuels optimism.
Via Chartmill · August 4, 2025
V2X Inc. (NYSE:VVX) beat Q2 2025 earnings estimates, raising full-year EPS guidance. Shares surged 3.9% post-release, reflecting strong defense sector performance.
Via Chartmill · August 4, 2025
BioMarin Pharmaceutical beats Q2 2025 estimates with $825.4M revenue, EPS of $1.44, and raises full-year guidance. Stock surges 4.6% post-earnings.
Via Chartmill · August 4, 2025
James River Group's Q2 2025 earnings missed revenue estimates but showed resilience in adjusted income, with shares remaining flat post-release.
Via Chartmill · August 4, 2025
ONEOK reports Q2 2025 earnings above estimates, reaffirms full-year guidance. Strong NGL performance in Rocky Mountain region drives results. Stock rises slightly post-announcement.
Via Chartmill · August 4, 2025
Get insights into the S&P500 index performance on Monday. Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill · August 4, 2025
Here are the top movers in Monday's session, showcasing the stocks with significant price changes.
Via Chartmill · August 4, 2025
Let's have a look at what is happening on the US markets on Monday. Below you can find the most active S&P500 stocks in today's session.
Via Chartmill · August 4, 2025
Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.
Via Chartmill · August 4, 2025
Let's have a look at what is happening on the US markets on Monday. Below you can find the S&P500 stocks with an unusual volume in today's session.
Via Chartmill · August 4, 2025
Unusual volume stocks are being observed in Monday's session.
Via Chartmill · August 4, 2025
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
Via Chartmill · August 4, 2025
Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · August 4, 2025
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index.
Via Chartmill · August 4, 2025
Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · August 4, 2025
CF Bankshares (CFBK) beats Q2 2025 revenue and EPS estimates, with earnings up 196% YoY, but stock shows muted reaction amid market caution.
Via Chartmill · August 4, 2025
Praxis Precision Medicines (PRAX) reports Q2 2025 results, highlighting strong clinical data for epilepsy drug vormatrigine with 56.3% seizure reduction. EPS beats estimates, stock rises pre-market.
Via Chartmill · August 4, 2025
ON Semiconductor reported mixed Q2 2025 results, beating revenue but missing EPS estimates. Stock dipped pre-market despite strong guidance amid sector challenges. Focus remains on automotive & industrial growth.
Via Chartmill · August 4, 2025
TE CONNECTIVITY PLC (TEL) offers a strong dividend profile with a 1.38% yield, 6.79% growth, and solid profitability. Its financial health and undervaluation make it a reliable pick for income-focused investors.
Via Chartmill · August 4, 2025
Curious about the S&P500 stocks that are showing activity before the opening bell on Monday?
Via Chartmill · August 4, 2025
Discover how Palantir (PLTR) aligns with the CAN SLIM investing strategy, showcasing strong earnings growth, market leadership, and technical momentum for potential breakout opportunities.
Via Chartmill · August 4, 2025
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · August 4, 2025
Hagerty Inc. (HGTY) beats Q2 2025 earnings estimates, raises full-year outlook, and sees shares surge 5% pre-market on strong revenue and EPS growth.
Via Chartmill · August 4, 2025
Wayfair's Q2 earnings beat estimates with $3.27B revenue and $0.87 EPS, driving shares up 12% pre-market. Strong growth signals resilience.
Via Chartmill · August 4, 2025
TG Therapeutics reported mixed Q2 2025 results, missing revenue and EPS estimates but raising full-year BRIUMVI sales guidance. Shares dipped slightly as investors weighed the outlook.
Via Chartmill · August 4, 2025
BioCryst Pharmaceuticals (BCRX) beats Q2 2025 estimates with strong revenue and profit growth, driven by ORLADEYO sales. Shares rise ~5% pre-market.
Via Chartmill · August 4, 2025
Lindblad Expeditions reports strong Q2 2025 results with revenue and EPS beating estimates, driving a 5.3% pre-market stock surge. Demand for adventure travel remains robust.
Via Chartmill · August 4, 2025
Tyson Foods beats Q3 estimates with strong chicken demand, shares rise 5%. Revenue hits $13.88B, EPS $0.91. Raised 2025 outlook boosts investor confidence.
Via Chartmill · August 4, 2025
Tower Semiconductor (TSEM) reported mixed Q2 2025 results, with revenue slightly below estimates but EPS beating forecasts. Shares rose 5.9% pre-market on strong guidance.
Via Chartmill · August 4, 2025
Krystal Biotech (KRYS) Q2 2025 earnings beat estimates with $96M revenue and $1.29 EPS, driven by VYJUVEK success. Shares rose 4% pre-market.
Via Chartmill · August 4, 2025
Inspire Medical Systems (NYSE:INSP) offers strong growth, fair valuation, and solid financial health, making it an ideal pick for affordable growth investors.
Via Chartmill · August 4, 2025